StonvexLoading…
StonvexStonvexStonvexCore line items from WEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $2.18B | $2.25B | $2.18B | $2.10B |
Operating Income | $343.45M | $371.36M | $381.98M | $353.31M |
Net Income | $165.07M | $194.36M | $204.44M | $177.37M |
EPS (Diluted) | $0.85 | $0.95 | $0.97 | $0.82 |
Total Assets | $4.96B | $5.03B | $5.18B | $5.50B |
Total Liabilities | $4.84B | $4.78B | $4.87B | $5.03B |
Cash & Equivalents | $300.83M | $450.51M | $516.04M | $745.89M |
Free Cash Flow OCF − CapEx | $242.62M | $260.92M | $260.39M | $174.36M |
Shares Outstanding | 190.32M | 203.83M | 205.40M | 213.10M |